巴戟天寡糖对抑郁症患者血浆BDNF,GDNF,VEGF和IGF-1水平的影响

被引：48

作者：

邓朔 ^{[1
]}

宓为峰 ^{[1
]}

徐意 ^{[2
]}

李志猛 ^{[2
]}

贾海涛 ^{[3
]}

唐新龙 ^{[4
]}

李玲芝 ^{[1
]}

郭丽华 ^{[1
]}

施莹 ^{[1
]}

张鸿燕 ^{[1
]}

机构：

[1] 北京大学第六医院北京大学精神卫生研究所卫生部精神卫生学重点实验室(北京大学)国家精神心理疾病临床医学研究中心(北京大学第六医院)

[2] 北京中研同仁堂医药研发有限公司

[3] 北京民康医院

[4] 安徽省六安市第二人民医院

来源：

中国新药杂志 | 2017年 / 26卷 / 20期

关键词：

巴戟天寡糖; 神经营养因子; 抑郁症;

D O I：

暂无

中图分类号：

R749.4 [情感性精神病];

学科分类号：

100204 [神经病学];

摘要：

目的:了解巴戟天寡糖对抑郁症患者血浆脑源性神经营养因子(BDNF)、胶质源性神经营养因子(GDNF)、血管内皮生长因子(VEGF)和胰岛素样生长因子(IGF-1)浓度的影响,探讨巴戟天寡糖治疗抑郁症前后BDNF,GDNF,VEGF和IGF-1的浓度变化与其疗效的关系。方法:本研究入组符合ICD-10的轻中度抑郁症门诊患者32例。入组后单一巴戟天抗抑郁治疗,每2周访视1次,记录患者的抑郁症状及服药情况,共治疗8周,入组前后各采血1次,采用酶联免疫吸附法测定患者血浆BDNF,GDNF,VEGF和IGF-1水平,同时以汉密尔顿抑郁量表(HAMD-17)评定患者的抑郁程度。结果:巴戟天寡糖抗抑郁治疗8周后,HAMD-17总分及各因子分显著降低(P<0.01);巴戟天寡糖治疗8周后,VEGF水平显著下降(Z=-2.354,P<0.05),BDNF和GDNF水平显著上升(Z=-4.157,P<0.01;Z=-4.345,P<0.01),而治疗前后IGF-1水平没有显著变化(Z=-0.901,P>0.05);治疗前后BDNF和GDNF浓度变化率与HAMD-17减分率呈正相关,其相关系数(r)分别为0.782(P<0.01)和0.456(P<0.05),而VEGF与IGF-1浓度变化率与HAMD-17减分率无关(分别为r=0.06,P>0.05;r=0.039,P>0.05)。结论:巴戟天寡糖可以改善BDNF,GDNF和VEGF的异常水平,但对IGF-1水平没有影响。

引用

页码：2454 / 2458

页数：5

共 15 条

[1]

Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis.[J].Hualin Zhang;Jun Li;Jingmin Xia;Sanqing Lin.International Journal of Biological Macromolecules.2013,

[2]

Possible contribution of IGF-1 to depressive disorder [J].

Szczesny, Ewa ;

Slusarczyk, Joanna ;

Glombik, Katarzyna ;

Budziszewska, Boguslawa ;

Kubera, Marta ;

Lason, Wladyslaw ;

Basta-Kaim, Agnieszka .

PHARMACOLOGICAL REPORTS, 2013, 65 (06) :1622-1631

[3]

Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders.[J].Bun-Hee Lee;Yong-Ku Kim.Journal of Affective Disorders.2011, 1

[4]

Altered expression of neurotrophic factors in patients with major depression [J].

Otsuki, Koji ;

Uchida, Shusaku ;

Watanuki, Toshio ;

Wakabayashi, Yusuke ;

Fujimoto, Michiko ;

Matsubara, Toshio ;

Funato, Hiromasa ;

Watanabe, Yoshifumi .

JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (14) :1145-1153

[5]

A neurotrophic model for stress-related mood disorders [J].

Duman, Ronald S. ;

Monteggia, Lisa M. .

BIOLOGICAL PSYCHIATRY, 2006, 59 (12) :1116-1127

[6]

Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury [J].

Bakshi, A ;

Shimizu, S ;

Keck, CA ;

Cho, S ;

LeBold, DG ;

Morales, D ;

Arenas, E ;

Snyder, EY ;

Watson, DJ ;

McIntosh, TK .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (08) :2119-2134

[7]

Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity [J].

Karege, F ;

Bondolfi, G ;

Gervasoni, N ;

Schwald, M ;

Aubry, JM ;

Bertschy, G .

BIOLOGICAL PSYCHIATRY, 2005, 57 (09) :1068-1072

[8]

Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication.[J].Bettina Franz;Daniel J Buysse;Christine R Cherry;Nicola S Gray;Victoria J Grochocinski;Ellen Frank;David J Kupfer.Journal of Psychiatric Research.1998, 2

[9]

Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients [J].